Caricamento...
Enhancing Chimeric Antigen Receptor T Cell Efficacy in Solid Tumors
Chimeric antigen receptor (CAR) T cell therapy has been acclaimed as a revolution in cancer treatment following the impressive results in hematological malignancies. Unfortunately, in patients with solid tumors, objectives responses to CAR T cells are still anecdotal, and important issues are driven...
Salvato in:
| Pubblicato in: | Clin Cancer Res |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269829/ https://ncbi.nlm.nih.gov/pubmed/32015021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1835 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|